BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9455955)

  • 1. Clinical acumen and vestibular schwannoma.
    Moffat DA; Baguley DM; Beynon GJ; Da Cruz M
    Am J Otol; 1998 Jan; 19(1):82-7. PubMed ID: 9455955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Audiologic presentation of vestibular schwannomas in neurofibromatosis type 2.
    Lalwani AK; Abaza MM; Makariou EV; Armstrong M
    Am J Otol; 1998 May; 19(3):352-7. PubMed ID: 9596188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of six otologic diseases involving vertigo.
    Kentala E
    Am J Otol; 1996 Nov; 17(6):883-92. PubMed ID: 8915417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial nerve schwannomas: different manifestations and outcomes.
    Chung JW; Ahn JH; Kim JH; Nam SY; Kim CJ; Lee KS
    Surg Neurol; 2004 Sep; 62(3):245-52; discussion 452. PubMed ID: 15336872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of vestibular schwannoma growth and clinical implications.
    Agrawal Y; Clark JH; Limb CJ; Niparko JK; Francis HW
    Otol Neurotol; 2010 Jul; 31(5):807-12. PubMed ID: 20502379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences to hearing during the conservative management of vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.
    Godefroy WP; Kaptein AA; Vogel JJ; van der Mey AG
    Otol Neurotol; 2009 Oct; 30(7):968-74. PubMed ID: 19730147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifier.
    Nouraei SA; Huys QJ; Chatrath P; Powles J; Harcourt JP
    Clin Otolaryngol; 2007 Aug; 32(4):248-54. PubMed ID: 17651265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the effect of structured teaching on a group of tinnitus patients after vestibular schwannoma removal.
    Baguley DM; Beynon GJ; Moffat DA
    Am J Otol; 1998 Nov; 19(6):828-33. PubMed ID: 9831163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of vestibular schwannomas: an effective strategy.
    Ferri GG; Modugno GC; Pirodda A; Fioravanti A; Calbucci F; Ceroni AR
    Laryngoscope; 2008 Jun; 118(6):951-7. PubMed ID: 18438269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and onset of gaze modulation of tinnitus and increased sensitivity to noise after translabyrinthine vestibular schwannoma excision.
    Baguley DM; Phillips J; Humphriss RL; Jones S; Axon PR; Moffat DA
    Otol Neurotol; 2006 Feb; 27(2):220-4. PubMed ID: 16436993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic posturography findings predict balance status in vestibular schwannoma patients.
    Gouveris H; Stripf T; Victor A; Mann W
    Otol Neurotol; 2007 Apr; 28(3):372-5. PubMed ID: 17159494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-labyrinthine schwannomas: a report of two cases].
    Boutin P; Guth A; Bouccara D; el Garem H; Rey A; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 1998 Feb; 115(1):35-41. PubMed ID: 9765709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic markers of hearing loss in intralabyrinthine schwannomas: implications for management.
    Santos F; Linthicum FH; House JW; Wilkinson EP
    Otol Neurotol; 2011 Dec; 32(9):1542-7. PubMed ID: 22072265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The learning curve in vestibular schwannoma surgery.
    Welling DB; Slater PW; Thomas RD; McGregor JM; Goodman JE
    Am J Otol; 1999 Sep; 20(5):644-8. PubMed ID: 10503588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acoustic neuromas presenting with normal or symmetrical hearing: factors associated with diagnosis and outcome.
    Lustig LR; Rifkin S; Jackler RK; Pitts LH
    Am J Otol; 1998 Mar; 19(2):212-8. PubMed ID: 9520059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of jugular foramen schwannomas with hearing and facial nerve function preservation: a series of 23 cases and review of the literature.
    Sanna M; Bacciu A; Falcioni M; Taibah A
    Laryngoscope; 2006 Dec; 116(12):2191-204. PubMed ID: 17146395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric hearing loss: rule 3,000 for screening vestibular schwannoma.
    Saliba I; Martineau G; Chagnon M
    Otol Neurotol; 2009 Jun; 30(4):515-21. PubMed ID: 19395982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.